Sarepta Therapeutics Inc (SRPT)
127.36
+3.11
(+2.50%)
USD |
NASDAQ |
Apr 25, 16:00
127.36
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Price to Book Value: 13.91 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 13.57 |
| April 23, 2024 | 12.79 |
| April 22, 2024 | 12.77 |
| April 19, 2024 | 12.63 |
| April 18, 2024 | 12.73 |
| April 17, 2024 | 12.88 |
| April 16, 2024 | 12.81 |
| April 15, 2024 | 12.92 |
| April 12, 2024 | 13.42 |
| April 11, 2024 | 13.59 |
| April 10, 2024 | 13.80 |
| April 09, 2024 | 13.87 |
| April 08, 2024 | 13.80 |
| April 05, 2024 | 13.77 |
| April 04, 2024 | 13.74 |
| April 03, 2024 | 13.86 |
| April 02, 2024 | 13.87 |
| April 01, 2024 | 14.02 |
| March 28, 2024 | 14.14 |
| March 27, 2024 | 14.22 |
| March 26, 2024 | 14.01 |
| March 25, 2024 | 13.97 |
| March 22, 2024 | 13.93 |
| March 21, 2024 | 13.65 |
| March 20, 2024 | 13.77 |
| Date | Value |
|---|---|
| March 19, 2024 | 13.55 |
| March 18, 2024 | 13.54 |
| March 15, 2024 | 13.44 |
| March 14, 2024 | 13.52 |
| March 13, 2024 | 13.32 |
| March 12, 2024 | 13.32 |
| March 11, 2024 | 13.28 |
| March 08, 2024 | 13.58 |
| March 07, 2024 | 13.19 |
| March 06, 2024 | 13.14 |
| March 05, 2024 | 13.42 |
| March 04, 2024 | 13.53 |
| March 01, 2024 | 14.05 |
| February 29, 2024 | 13.97 |
| February 28, 2024 | 15.02 |
| February 27, 2024 | 15.46 |
| February 26, 2024 | 15.03 |
| February 23, 2024 | 14.91 |
| February 22, 2024 | 14.70 |
| February 21, 2024 | 14.43 |
| February 20, 2024 | 14.85 |
| February 16, 2024 | 14.68 |
| February 15, 2024 | 13.62 |
| February 14, 2024 | 13.56 |
| February 13, 2024 | 13.55 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.924
Minimum
Sep 26 2019
37.12
Maximum
Mar 07 2023
12.72
Average
11.70
Median
Jun 22 2020
Price to Book Value Benchmarks
| PTC Therapeutics Inc | -- |
| Vertex Pharmaceuticals Inc | 5.844 |
| Regenxbio Inc | 2.527 |
| CytomX Therapeutics Inc | -- |
| Apellis Pharmaceuticals Inc | 29.67 |
Price to Book Value Related Metrics
| PS Ratio | 9.465 |
| Price | 127.36 |
| Earnings Yield | -4.58% |
| Market Cap | 11.95B |